xylitol nasal spray
Commercial- Indications
- Upper respiratory infections, Sinus congestion, Chronic rhinosinusitis
Company intelligence / Profile preview
Xlear
American Fork, Utah, United Statesxlear.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Xlear’s flagship product, a xylitol-based saline nasal spray, has been shown in pilot studies to help manage chronic rhinosinusitis and may reduce symptoms of upper respiratory conditions. Some research suggests potential benefits against viral pathogens including SARS-CoV‑2 in vitro; however, these are not formal drug trials but rather support for its use as a hygiene adjunct.
“Xlear Nasal Hygiene works to cleanse, relieve, and soothe your sinuses and bolster your upper respiratory health.”
“Xylitol nasal irrigation in the management of chronic rhinosinusitis…a pilot study.”
“Further Evidence of Xylitol’s Effectiveness Against SARS-CoV‑2…”
“Comprehensive Literature Review of Intranasal Therapy Against SARS-CoV‑2…”
The company positions its products as natural alternatives for sinus care based on published research.
No evidence found that the company develops prescription drugs or conducts traditional clinical trials.
Products are available over-the-counter at major retailers.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Xlear.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xlear.